Related Experiment Video

Updated: Sep 28, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.5K

Trametinib for Painful Glomus Tumors in a Patient with Neurofibromatosis Type 1

Seth A Climans1,2, Ronald C Ramos1,3, Dimitri J Anastakis4

  • 1Departments of Neurology and Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|March 31, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
GlomangiomaNeuro-oncologyNeurofibromatosis type 1Plastic surgeryTargeted chemotherapy

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.2K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.4K

Related Concept Videos